Return to search

IPO Profile: Second Sight Medical Products Inc

Company Details

Sylmar, Calif.


Description: Second Sight Medical Products develops, manufactures and markets implantable visual prosthetics. The company creates retinal prosthesis to provide sight to subjects blinded from outer retinal degenerations, such as retinitis pigmentosa.

IPO Details

Exchange and Ticker: Nasdaq: EYES

Filing Range: 3.50 million shares @ $9.00 to $9.00

Offering Price: $9.00

Close price as of 11/19/14: $19.97

Offering Size: $31.5M

Shares Outstanding: 35.1M

Underwriters: MDB Capital Corp

Company Counsel: Law Office of Aaron A Grunfeld

Manager Counsel: Golenbock, Eiseman, Assor & Bell

Auditor: Gumbiner Savett Inc

Market Capitalization on 11/2814: $537.25M

Close price at current month end: $15.32

Investment Details

Venture Backers: Versant Ventures


  • 12/18/09 $5M
  • 2/29/12 $4M
  • 6/25/14 $5.75M
  • 7/18/14 $5M

Source: Thomson Reuters data